MELISSA ATKINSON: Open Payments
NPI 1184148181 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 48 payments from 11 companies in 2025. Trend: 2023 $361 · 2024 $874 · 2025 $959
Food & beverage: $869Education: $90
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $266 |
| Janssen Biotech, Inc. | 16 | $213 |
| Amgen Inc. | 8 | $210 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $90 |
| Hill Dermaceuticals, Inc. | 1 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| LEO Pharma Inc. | 1 | $15 |
Products named: DUPIXENT, TREMFYA, OTEZLA, Tolak, Rhapsido, SKYRIZI, COSENTYX, TALTZ.
Industry payments across KY — which companies pay providers there.
